| Molecular dynamics (MD) investigations of preformed structures of the transmembrane domain of the oncogenic Neu receptor dimer in a DMPC bilayer. | None |
| expression is regulated by fatty acid synthase and hypoxia-inducible factor-1alpha in cancer cells overexpressing her-2/neu oncogene | None |
| Oleic acid suppresses overexpression of ERBB2 oncogene. | None |
| [Expression of the cerbB-2 (HER-2/neu) oncoprotein in prostatic adenocarcinoma]. | None |
| Targeting and regulation of the HER-2/neu oncogene promoter with bis-peptide nucleic acids. | None |
| Soluble oncoprotein 185HER-2 in pleural fluid has limited usefulness for the diagnostic evaluation of malignant effusions. | None |
| Functional expression of a single-chain antibody specific for the HER2 human oncogene in a bacterial reducing environment. | None |
| Effect of gamma-linolenic acid on the transcriptional activity of the Her-2/neu (erbB-2) oncogene. | None |
| FAK signaling is critical for ErbB-2/ErbB-3 receptor cooperation for oncogenic transformation and invasion. | None |
| Preliminary evaluation of HER-2/neu oncogene and epidermal growth factor receptor expression in normal and neoplastic human ovaries. | None |
| Prostatic intraepithelial neoplasia and adenocarcinoma in mice expressing a probasin-Neu oncogenic transgene. | None |
| Systematic molecular dynamics searching in a lipid bilayer: application to the glycophorin A and oncogenic ErbB-2 transmembrane domains. | None |
| Re: Effect of gamma-linolenic acid on the transcriptional activity of the Her-2/neu (erbB-2) oncogene. | None |
| Adenovirus type 5 E1A gene products act as transformation suppressors of the neu oncogene. | None |
| Repressed expression of the HER-2/c-erbB-2 proto-oncogene by the adenovirus E1a gene products. | None |
| Expression of c-erbB-2 oncoprotein in salivary gland tumours: an immunohistochemical study. | None |
| An antigen immunologically related to the external domain of gp185 is shed from nude mouse tumors overexpressing the c-erbB-2 (HER-2/neu) oncogene. | None |
| Correlation of c-erbB-2 oncogene and p53 tumor suppressor gene with malignant transformation of hydatidiform mole. | None |
| Oncogenic forms of the neu/HER2 tyrosine kinase are permanently coupled to phospholipase C gamma. | None |
| Biological effects of monoclonal antireceptor antibodies reactive with neu oncogene product, p185neu. | None |